Eli Lilly & Co. said Tuesday it’s cutting the price of single-dose vials of its Zepbound treatment for diabetes and obesity for patients who have to pay for the drug themselves. It said it will ...

The Danish drugmaker on Friday abruptly announced that longtime CEO Lars Fruergaard Jørgensen is stepping down, as its obesity injection Wegovy loses ground to Eli Lilly's rival treatment ...

The success of Eli Lilly & Co.'s weight-loss and diabetes drugs has pushed the company's stock to new heights, helping the founding family's endowment become the largest private foundation in the ...

WASHINGTON – Seated before a panel of senators, with a crowd of others who lost loved ones in the Tops Market massacre at his back, former Buffalo Fire Commissioner Garnell Whitfield on Tuesday ...

Eli Lilly (NYSE: LLY) is gaining market share in a lucrative market that could be a catalyst for a stock price increase. *Stock prices used were the afternoon prices of May 14, 2025. The video was ...

You miss 100 percent of the shots you don’t take? Philadelphia Eagles cornerback and Super Bowl champion Eli Ricks learned that lesson in a pretty hilarious way — and got quite the surprise ...

The pharmaceutical giant has been racing against rivals such as Eli Lilly to dominate the highly lucrative weight-loss space. Morgan Stanley Research is projecting that the global market for ...

May 16 (Reuters) - The U.S. Food and Drug Administration has cleared Fujirebio Diagnostics' blood test to diagnose Alzheimer's disease, the regulator said on Friday, making the device the first of ...

While many pharma and biotech companies developing drugs to treat Alzheimer's disease are targeting amyloid beta plaque, Eli Lilly (NYSE:LLY) is looking at other targets as well. The drugmaker's ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other best major stocks to buy according to billionaires. The U.S. stock market had one of the ...